Importance of EGFR change as a surrogate end point of ESRD in a randomized controlled trial

Category Primary study
JournalJournal of the American Society of Nephrology
Year 2017
This article has no abstract
Epistemonikos ID: 4d135e311a8208e68993574b69fc00f75599b220
First added on: Feb 12, 2025